acetazolamide has been researched along with Cheyne-Stokes Respiration in 11 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Cheyne-Stokes Respiration: An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acetazolamide has been used to attenuate Hunter-Cheyne-Stokes breathing with central sleep apnea (CSA) associated with heart failure." | 9.19 | Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. ( Edwards, BA; Javaheri, S; Sands, SA, 2014) |
| "Acetazolamide has been used to attenuate Hunter-Cheyne-Stokes breathing with central sleep apnea (CSA) associated with heart failure." | 5.19 | Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. ( Edwards, BA; Javaheri, S; Sands, SA, 2014) |
| " No apnea was seen before timolol maleate administration, and no further spells were noted after subsequent cyclocryotherapy without timolol maleate treatment." | 3.66 | Apneic spells associated with timolol therapy in a neonate. ( Bromberg, BB; Olson, RJ; Zimmerman, TJ, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Javaheri, S | 1 |
| Sands, SA | 1 |
| Edwards, BA | 1 |
| Bekfani, T | 1 |
| Abraham, WT | 1 |
| Badr, S | 1 |
| Fontana, M | 1 |
| Emdin, M | 1 |
| Giannoni, A | 1 |
| Iudice, G | 1 |
| Baruah, R | 1 |
| Passino, C | 1 |
| Brack, T | 1 |
| Randerath, W | 1 |
| Bloch, KE | 1 |
| Yasuma, F | 1 |
| Murohara, T | 1 |
| Hayano, J | 1 |
| Sanner, B | 1 |
| Schäfer, T | 1 |
| Findley, LJ | 1 |
| Blackburn, MR | 1 |
| Goldberger, AL | 1 |
| Mandell, AJ | 1 |
| Olson, RJ | 1 |
| Bromberg, BB | 1 |
| Zimmerman, TJ | 1 |
| Tojima, H | 1 |
| Cho, K | 1 |
| Okita, S | 1 |
| Kunitomo, F | 1 |
| Yuguchi, Y | 1 |
| Kuriyama, T | 1 |
| Watanabe, S | 1 |
| Honda, Y | 1 |
| Gotoh, F | 1 |
| Meyer, JS | 1 |
| Takagi, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Oxygen Therapy on Readmissions of Patients With Chronic Heart Failure With Reduced Ejection Fraction[NCT05913739] | 36 participants (Anticipated) | Interventional | 2023-07-01 | Recruiting | |||
| Different Loop Gain Phenotypes in Patients With Chronic Systolic Heart Failure and Periodic Breathing[NCT03532412] | 12 participants (Actual) | Observational | 2016-06-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for acetazolamide and Cheyne-Stokes Respiration
| Article | Year |
|---|---|
Current and future developments in the field of central sleep apnoea.
Topics: Acetazolamide; Cardiac Resynchronization Therapy; Cheyne-Stokes Respiration; Continuous Positive Air | 2016 |
Central sleep apnea in patients with congestive heart failure.
Topics: Acetazolamide; Anticonvulsants; Bronchodilator Agents; Cheyne-Stokes Respiration; Heart Failure; Hum | 2009 |
Cheyne-Stokes respiration in patients with heart failure: prevalence, causes, consequences and treatments.
Topics: Acetazolamide; Carbon Dioxide; Cheyne-Stokes Respiration; Heart Failure; Humans; Oxygen Inhalation T | 2012 |
[Central sleep apnea syndrome].
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Bronchodilator Agents; Cardiovascular Diseases; C | 2008 |
2 trials available for acetazolamide and Cheyne-Stokes Respiration
| Article | Year |
|---|---|
Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure.
Topics: Acetazolamide; Aged; Blood Gas Analysis; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Chemorecepto | 2014 |
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Cheyne-Stokes Respiration; Female; Heart Failure | 2011 |
5 other studies available for acetazolamide and Cheyne-Stokes Respiration
| Article | Year |
|---|---|
Long-term efficacy of acetazolamide on Cheyne-Stokes respiration in congestive heart failure.
Topics: Acetazolamide; Cheyne-Stokes Respiration; Diuretics; Heart Failure; Humans; Sleep Apnea, Central; Tr | 2006 |
Apneas and oscillation of cardiac ectopy in Cheyne-Stokes breathing during sleep.
Topics: Acetazolamide; Aged; Cardiac Complexes, Premature; Cheyne-Stokes Respiration; Electrocardiography; H | 1984 |
Apneic spells associated with timolol therapy in a neonate.
Topics: Acetazolamide; Apnea; Asphyxia Neonatorum; Cheyne-Stokes Respiration; Cryosurgery; Glaucoma; Humans; | 1979 |
[A case of Cheyne-Stokes respiration--a mechanism of ventilatory control and the effect of acetazolamide].
Topics: Acetazolamide; Aged; Cheyne-Stokes Respiration; Female; Humans; Respiration; Respiration Disorders | 1986 |
Cerebral venous and arterial blood gases during Cheyne-Stokes respiration.
Topics: Acetazolamide; Adult; Aged; Blood Gas Analysis; Carbon Dioxide; Cerebrovascular Disorders; Cheyne-St | 1969 |